logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Martine Piccart

Novartis
H指数:149
被引数:11.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Postmastectomy radiation therapy in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer: a retrospective exploratory cohort analysis of the adjuvant lapatinib and/or trastuzumab treatment optimization (ALTTO) trial [BIG 2-06/NCCTG N063D (Alliance)]

人表皮生长因子受体2（HER2）阳性乳腺癌患者中的术后放疗：辅助拉帕替尼和/或曲妥珠胺治疗优化（ALTTO）试验（BIG 2-06/NCCTG N063D（Alliance））的回顾性探索性队列分析

EClinicalMedicine
IF10
2026-07-010
PRE
De Santis, Maria Carmen; Campbell, Christine; Samy, Faye; De Rose, Fiorenza; Meduri, Bruno; Lambertini, Matteo; Sotiriou, Christos; Carnevale, Maria Grazia; Ferro, Antonella; Saura, Cristina; Choudhury, Anup; Giandini, Carlotta; Verderio, Paolo; Chumsri, Saranya; Appierto, Valentina; Piccart, Martine; Pruneri, Giancarlo; Colciago, Riccardo Ray; de Azambuja, Evandro; Di Cosimo, Serena
The Breast International Group (BIG) Patient Partnership: Embedding Meaningful Patient Involvement in the Design and Conduct of Breast Cancer Clinical Research

乳腺癌国际组织(BIG)患者伙伴关系：将有意义的患者参与嵌入乳腺癌临床研究的设计与实施

The Breast
IF0
2025-11-100
OAAI
Carmela Caballero; Virginie Adam; Orsolya Birta; Lydie Meheus; Judy Needham; Christine Hodgdon; Leslie Gilhams; Concepcion Biurrun; Mairead MacKenzie; Tanja Spanic; Hilary Stobart; Lynda Belhadi; Julia Maués; Ana Casas; Eva Schumacher-Wulf; Carolyn Straehle; Seamus O’Reilly; David Cameron; Martine Piccart; Judith Bliss
Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]

勘误：“Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]

The Breast
IF0
2025-09-220
PREAI
Isabelle Demeestere; Samuel M. Niman; Ann H. Partridge; Daniela S. Diego; Roswitha Kammler; Monica Ruggeri; Marco Colleoni; Chikako Shimizu; Cristina Saura; Karen A. Gelmon; Anna B. Saetersdal; Judith R. Kroep; Audrey Mailliez; Frederic Amant; Manuel Ruız-Borrego; Jeong Eon Lee; Akemi Kataoka; Janice M. Walshe; Junko Takei; Simona Borstnar; Virginia F. Borges; Christobel Saunders; Snezana Susnjar; Vesna Bjelic-Radisic; Fatima Cardoso; Jane Lowe Meisel; Jennifer F. Kawwass; Tanja Spanic; Sarra El-Abed; Martine Piccart; Larissa A. Korde; Aron Goldhirsch; Richard D. Gelber; Olivia Pagani; Hatem A. Azim; Fedro A. Peccatori
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial

POSITIVE试验中，预测乳腺癌患者为尝试生育而中断辅助内分泌治疗时生育力的激素因素

breast
IF0
2025-07-260
OAAI
Isabelle Demeestere; Samuel M. Niman; Ann H. Partridge; Daniela S. Diego; Roswitha Kammler; Monica Ruggeri; Marco Colleoni; Chikako Shimizu; Cristina Saura; Karen A. Gelmon; Anna B. Saetersdal; Judith R. Kroep; Audrey Mailliez; Frederic Amant; Manuel Ruız-Borrego; Jeong Eon Lee; Akemi Kataoka; Janice M. Walshe; Junko Takei; Simona Borstnar; Virginia F. Borges; Christobel Saunders; Snezana Susnjar; Vesna Bjelic-Radisic; Fatima Cardoso; Jane Lowe Meisel; Jennifer F. Kawwass; Tanja Spanic; Sarra El-Abed; Martine Piccart; Larissa A. Korde; Aron Goldhirsch; Richard D. Gelber; Olivia Pagani; Hatem A. Azim; Fedro A. Peccatori
Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication model

雌激素受体阳性早期乳腺癌的预后和治疗预测：将70基因签名整合到PREDICT预后模型中

breast
IF0
2025-07-190
PREAI
Ellen G. Engelhardt; Mary Ann E. Binuya; Paul D.P. Pharoah; Coralie Poncet; Emiel J.T. Rutgers; Martine Piccart; Fatima Cardoso; Laura J. van ‘t Veer; Ewout W. Steyerberg; Sabine C. Linn; Marjanka K. Schmidt
The association of high body mass index with the safety and efficacy of sacituzumab govitecan in patients with metastatic triple-negative breast cancer from the ASCENT study

ASCENT研究中，体重指数与转移性三阴性乳腺癌患者中sacituzumab govitecan的安全性和有效性之间的关联

ESMO Open
IF8.3
2025-06-010
OA
L. García-Estévez; A. Bardia; H.S. Rugo; L.A. Carey; V.C. Diéras; S. Loibl; M. Piccart; L. Gianni; K. Kalinsky; J. O’Shaughnessy; S.A. Hurvitz; E. Harting; T. Valdez; S. Phan; C. Lai; J. Cortés
ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)

ESMO临床获益程度量表2.0版（ESMO-MCBS v2.0）

Annals of Oncology
IF65.4
2025-05-220
PRE
N.I. Cherny; S.F. Oosting; U. Dafni; N.J. Latino; M. Galotti; P. Zygoura; G. Dimopoulou; T. Amaral; J. Barriuso; A. Calles; B. Kiesewetter; C. Gomez-Roca; B. Gyawali; M. Piccart; A. Passaro; F. Roitberg; N. Tarazona; D. Trapani; G. Curigliano; R. Wester; E.G.E. de Vries
Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study

真实世界中接受辅助紫杉醇联合曲妥珠单抗（APT）方案治疗的I期HER2阳性早期乳腺癌患者的5年结果：一项国际回顾性研究

Clinical Breast Cancer
IF2.5
2025-05-150
PRE
Soraia Lobo-Martins; Veronique Debien; Elisa Agostinetto; Marianna Sirico; Giselle de Souza Carvalho; Flavia Jacobs; Chiara Molinelli; Renata Colombo Bonadio; Pedro Bergmann; Cristiano de Pádua Souza; Laura Testa; Marina Nishimuni; André João Rossi; Gabriel Kamei Guimarães; Michel Moreau; Ugo De Giorgi; José Bines; Armando Santoro; Donatienne Taylor; Francois P. Duhoux; Giacomo Barchiesi; Matteo Lambertini; Martine Piccart; Evandro de Azambuja
Adapting radiation therapy to immunotherapy: Delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial
RADIOTHERAPY AND ONCOLOGY
IF5.3
2025-05-010
PRE
Caluwe, A. De; Bellal, S.; Cao, K.; Peignaux, K.; Remouchamps, V.; Baten, A.; Longton, E.; Bessieres, I.; Vu-Bezin, J.; Kirova, Y.; Van Gestel, D.; Desmoulins, I.; Ignatiadis, M.; Romano, E.; Buisseret, L.; Piccart, M.; Vandekerkhove, C.; Gulyban, A.; Poortmans, P.
Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trial

在APHINITY试验中，他汀类药物使用与早期HER2阳性乳腺癌患者生存结局的关联

BREAST CANCER RESEARCH AND TREATMENT
IF3
2025-04-280
OA
Maurer, Christian; Agostinetto, Elisa; Ameye, Lieveke; Lambertini, Matteo; Martel, Samuel; Ponde, Noam; Brandao, Mariana; Poggio, Francesca; Ferreira, Arlindo; Schiff, Rachel; De Angelis, Carmine; Gelber, Richard D.; Dent, Susan; Thomssen, Christoph; Piccart, Martine; de Azambuja, Evandro
Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions (vol 31, pg 3569, 2012)

建模浸润性乳腺癌：生长因子推动HER2阳性癌前病变的进展（卷31，页3569，2012）

ONCOGENE
IF7.3
2025-04-110
PRE
Pradeep, C. -R; Zeisel, A.; Kostler, W. J.; Lauriola, M.; Jacob-Hirsch, J.; Haibe-Kains, B.; Amariglio, N.; Ben-Chetrit, N.; Emde, A.; Solomonov, I.; Neufeld, G.; Piccart, M.; Sagi, I.; Sotiriou, C.; Rechavi, G.; Domany, E.; Desmedt, C.; Yarden, Y.
Tailoring neo/adjuvant systemic therapy in breast cancer: The advent of a personalized approach-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations

定制乳腺癌的新/辅助系统治疗: 个性化方法的出现-乳腺妇科和免疫肿瘤学国际癌症会议 (BGICC) 共识和建议

CANCER
IF5.1
2024-07-100
PRE
Elghazaly, Hesham; Azim, Hamdy A.; Rugo, Hope S.; Cameron, David; Swain, Sandra M.; Curigliano, Giuseppe; Harbeck, Nadia; Tripathy, Debu; Arun, Banu; Aapro, Matti; Piccart, Martine; Cardoso, Fatima; Gligorov, Joseph; Elghazawy, Hagar; El Saghir, Nagi S.; Penault-Llorca, Frederique; Perez, Edith A.; Poortmans, Philip; Abdelaziz, Hany; El-Zawahry, Heba M.; Kassem, Loay; Sabry, Mohamed; Viale, Giuseppe; Al-Sukhun, Sana; Gado, Neven; Leung, Jessica W. T.; Ezz Elarab, Lobna; Cardoso, Maria Joao; Abdel Karim, Khaled; Foheidi, Meteb; Elmaadawy, Merit M.; Conte, Pierfranco; Selim, Ashraf S. M.; Kandil, Alaa; Kamal, Rasha M.; Paltuev, Ruslan M.; Guarneri, Valentina; Abulkhair, Omalkhair; Zakaria, Omar; Golshan, Mehra; Orecchia, Roberto; Elmahdy, Manal; Abdel-Aziz, Ahmed M.; Eldin, Nermean Bahie
Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer (vol 8, 98, 2022)

sacituzumab govitecan治疗转移性三阴性乳腺癌的3期ASCENT试验的安全性分析 (第8、98、2022卷)

NPJ BREAST CANCER
IF7.6
2024-06-060
OAAI
Rugo, Hope S.; Tolaney, Sara M.; Loirat, Delphine; Punie, Kevin; Bardia, Aditya; Hurvitz, Sara A.; O'Shaughnessy, Joyce; Cortes, Javier; Dieras, Veronique; Carey, Lisa A.; Gianni, Luca; Piccart, Martine J.; Loibl, Sibylle; Goldenberg, David M.; Hong, Quan; Olivo, Martin; Itri, Loretta M.; Kalinsky, Kevin
Fertility preservation and assisted reproductive technologies (ART) in breast cancer (BC) patients (pts) interrupting endocrine therapy (ET) to attempt pregnancy
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Azim, Hatem; Niman, Samuel; Partridge, Ann; Demeestere, Isabelle; Ruggeri, Monica; Colleoni, Marco; Saura, Cristina; Shimizu, Chikako; Saetersdal, Anna; Kroep, Judith; Mailliez, Audrey; Warner, Ellen; Borges, Virginia; Amant, Frederic; Gombos, Andrea; Kataoka, Akemi; Rousset-Jablonski, Christine; Borstnar, Simona; Takei, Junko; Lee, Jeong Eon; Walshe, Janice; Ruiz-Borrego, Manuel; Moore, Halle; Saunders, Christobel; Bjelic-Radisic, Vesna; Susnjar, Snezana; Cardoso, Fatima; Klar, Natalie; Spanic, Tanya; Ruddy, Kathryn; Piccart, Martine; Korde, Larissa; Goldhirsch, Aron; Gelber, Richard; Pagani, Olivia; Peccatori, Fedro Alessandro

研究方向

暂未获取到该数据
C
Christos Sotiriou
H 指数:122论文数:1,108被引数:7.9万
E
Evandro de Azambuja
H 指数:85论文数:727被引数:3.8万
D
Denis Larsimont
H 指数:78论文数:659被引数:3.8万
F
Fátima Cardoso
H 指数:103论文数:824被引数:6.5万
C
Christine Desmedt
H 指数:75论文数:640被引数:5.0万
A
Ahmad Awada
H 指数:75论文数:1,009被引数:2.5万
R
Richard D. Gelber
H 指数:133论文数:594被引数:9.0万
M
Michail Ignatiadis
H 指数:54论文数:323被引数:1.5万
F
Françoise Rothé
H 指数:40论文数:312被引数:7,199
S
Sherene Loi
H 指数:126论文数:1,217被引数:7.9万